William P. Fay, MD

William P. Fay, MD

Program Director (PD)

Bio

William Fay, MD, is Professor of Medicine and Senior Associate Dean for Research in the MU School of Medicine, where he holds the J.W. and Lois Winifred Stafford Distinguished Chair in Diabetes and Cardiovascular Research. He is also an Investigator of the Dalton Cardiovascular Research Center. Dr. Fay's research interests focus on vascular biology, atherosclerosis, and thrombosis. His lab is currently carrying out studies of novel compounds for the prevention of restenosis and atherosclerosis that are funded by NIH and AHA. Dr. Fay has served on the AHA National Research Committee and chaired the ATVB annual meeting. He is the recipient of a Thrombosis Special Recognition Award from the ATVB Council. Dr. Fay is a practicing cardiologist. He has served on numerous STTR/SBIR study sections and has been a co-investigator on 3 NIH SBIR grants. He is a member of the MU Coulter Executive Committee.

Sheila Grant, PhD

Sheila Grant, PhD

Program Director (PD)

Bio

Sheila Grant, PhD, is Associate Vice Chancellor of Research & Strategic Initiatives, MU, Associate Dean of Research, College of Engineering, and Professor of Bioengineering. Dr. Grant’s research focuses on optical biosensors and biomaterials and has been funded by the NSF, NIH, USDA, DOD-Army, and numerous industries (Medtronic, Covidien, J&J, MTF, W.L. Gore). Dr. Grant holds eight U.S. patents, has published over 100 research articles in scientific journals, and is the founder of three start-up companies. Dr. Grant is the sub-contract PI on a current NSF SBIR and served as a NIH SBIR/STTR Panel Chairperson (IMST, Section 13 and BST-10 IRG) for two years. She is a member of the MU Coulter Executive Committee. Dr. Grant is a Fellow of the National Academy of Inventors, a Fellow of the Biomedical Engineering Society, and a Fellow of the American Institute for Medical and Biological Engineering (AIMBE).

Bill Turpin, MBA

Bill Turpin, MBA

Program Director (PD)

Bio

Bill Turpin, MBA, obtained a BS in Electrical Engineering from the University of Missouri and an Executive MBA from the University of Texas. He is President and CEO of the Missouri Innovation Center in Columbia, Missouri. Bill works with faculty and students from the University of Missouri and local entrepreneurs to start and grow technology-based companies. MIC also operates the MU Life Sciences Business Incubator at Monsanto Place with over 60 clients commercializing new technologies in areas including medical devices and pharmaceuticals. With over 30 years of experience as a serial entrepreneur, Bill has the insight and connections to help launch successful companies. He has been the founding CEO of 4 startups and a senior executive at respected public companies including Netscape and Borland. One of his startups pioneered the use of dynamically created web pages and invented the JavaScript programming language. He participated in the groundbreaking Netscape IPO in 1995. He has successfully secured investments from prominent venture capitals firms, including Kleiner Perkins, and was an Entrepreneur in Residence at Redpoint Ventures. And along the way, Bill has served as a mentor and angel investor to many Silicon Valley startups. Bill moved back to Columbia in 2014 to share his experience with promising entrepreneurs and build out the entrepreneurial ecosystem in Mid Missouri. Bill created the MIC Technology Accelerator Fund and raised over $2 million to help commercialize new digital technologies. Bill currently serves on the board of directors for Tensive Controls - which has received significant funding from NCI for a novel therapeutic to treat cachexia.

Jaya Ghosh, PhD

Jaya Ghosh, PhD

Lead Program Manager

Bio

Jaya Ghosh, PhD, works closely with applying and funded researchers in MBArC. Dr. Ghosh has considerable experience in translational project management, having served as the Assistant Program Director of the Coulter Translational Partnership Program at MU since 2015, and recently being promoted to the Program Director position. The MU Coulter Program bridges the gap between academic research and industry by accelerating the translation of biomedical innovations into products that improve patient care. As Coulter Program Director, Jaya is responsible for managing all processes associated with de-risking, funding, reviewing and tracking of Coulter projects. She teaches the Coulter Business Boot Camp which is offered annually. During the Boot Camp, teams of engineering faculty researchers and clinicians, mentored by the instructor, business advisers and experts, are guided through a series of lectures and interactive exercises to pressure-test the commercial viability of their ideas using universal business criteria as well as the unique requirements of biomedical product commercialization. Dr. Ghosh is also an adjunct Instructor in the Trulaske College of Business and a Program Manager for the NIH Concept to Clinic: Commercializing Innovation (C3i) Program. Before joining the MU Coulter Program, Jaya was the Engineering Fellow for the MU Biodesign & Innovation Program.

Douglas Wright, PhD

Douglas Wright, PhD

Co-Investigator

Bio

Douglas Wright, PhD, is Professor and Vice Chair, Department of Anatomy & Cell Biology, KUMC, PI of K-INBRE, and Co-PI of SHARPhub. Doug’s main research interests are peripheral nerves, sensation, and pain. Within MBArC, Dr. Wright serves as a Co-investigator of the overall project and a member of the overall Hub Leadership Team. Dr. Wright helps to identify and recruit scientific teams from KUMC and other institutions within K-INBRE and SHARPhub whose scientific discoveries have commercialization potential.

Photo of Richard Barohn, MD

Richard Barohn, MD

Advisor

Bio

Richard Barohn, MD, is vice chancellor for health affairs for MU Health Care and MU School of Medicine. Previously, he was professor and chair of the Department of Neurology, University of Kansas Medical Center (KUMC). He is PI of the Frontiers: University of Kansas Clinical and Translational Science Institute. Dr. Barohn is a member of the National CTSA Executive Committee. He is an internationally-recognized expert in clinical trials of drugs used to treat neuromuscular disorders who is committed to finding new therapies to help patients with rare neuromuscular diseases. Within MBArC, Dr. Barohn serves as an advisor on the project and a member of the overall Hub Leadership Team. His expertise as a clinician-scientist with extensive experience in clinical trials proves useful in all aspects of MBArC. Dr. Barohn helps to identify and recruit scientific teams from KUMC and serve as the lead contact between KUMC, MU, and its UM System partners.